.webp)
A cancer diagnosis turns your world upside down. And then comes the second blow — the cost estimate. $150,000 in the USA. £80,000 in the UK. For millions of patients across Africa, the Middle East, and Central Asia, those numbers aren't just difficult — they're impossible. India offers the same oncology technology, the same clinical outcomes, and the same international accreditation, at 60-80% lower cost. This is your complete, honest guide.
Every major cancer treatment available in the West is available in India. In some areas — particularly robotic oncology and CAR-T cell therapy — India is genuinely at the global frontier.
India's top cancer hospitals manage some of the highest volumes of oncology cases in Asia. Apollo Cancer Centres treat over 20,000 international patients annually. Tata Memorial Centre in Mumbai — established in 1941 — is one of the oldest and most distinguished cancer institutions in the world. The surgeons and oncologists at these institutions trained at Harvard, Oxford, MD Anderson, and Memorial Sloan Kettering before returning to build India's own cancer legacy.
India is home to South Asia's first proton therapy centre at Apollo Proton Cancer Centre in Chennai. The country became one of the first in Asia to approve and administer CAR-T cell therapy using the indigenously developed NexCAR19 — at approximately 10% of equivalent US pricing. The SSI Mantra, India's first domestically developed surgical robot, is extending robotic oncology into cities previously underserved by this technology.
The hospitals in this guide hold JCI (Joint Commission International) and NABH accreditation. JCI is the global gold standard — the same body that certifies Johns Hopkins, Cleveland Clinic, and Charite Berlin. Accreditation governs surgical protocols, infection control, nursing ratios, record-keeping, and patient safety frameworks. It is not cosmetic.
Surgical tumour removal remains the cornerstone of curative oncology for most solid cancers. India offers open, laparoscopic, and robotic-assisted surgery for virtually all cancer types. Robotic platforms — including the da Vinci Surgical System and the domestically developed SSI Mantra — provide superior precision in tumour excision, less blood loss, and faster recovery, particularly for prostate, colorectal, gynaecological, and head & neck cancers.
Robotic cancer surgery in India costs approximately $5,000-$12,000, compared to $30,000-$60,000 in the USA.
India's oncology pharmacies stock both branded and bioequivalent generic drugs. The same molecular entities used in US and UK protocols are used in India. Chemotherapy per cycle in India costs $400-$2,500 depending on the drug regimen and hospital tier — a fraction of Western pricing for identical treatment.
India's leading cancer centres offer the complete spectrum of radiation modalities:
India's top hospitals administer the full range of targeted agents (Trastuzumab, Bevacizumab, Osimertinib, Imatinib) and checkpoint inhibitors (Pembrolizumab / Keytruda, Nivolumab / Opdivo). Generic versions of many targeted therapies are widely produced in India under WTO compulsory licensing frameworks, making drugs like Pembrolizumab available at approximately one-third of US list price.
India's NexCAR19 is one of the most significant cancer therapy developments in Asia in the past decade. Developed collaboratively by IIT Bombay and Tata Memorial Centre, this indigenously produced CAR-T therapy is approved by India's CDSCO and treats relapsed/refractory blood cancers at $35,000-$60,000 — an 80-85% reduction compared to US-priced CAR-T products ($350,000-$500,000).
CAR-T cell therapy modifies the patient's own T-cells to recognise and destroy cancer cells. For blood cancer patients (B-cell lymphoma, ALL) who have failed other treatments, this is potentially life-saving access that was previously financially impossible.
India has established high-volume BMT programmes for leukaemia, lymphoma, myeloma, and aplastic anaemia. BMT in India costs $25,000-$55,000 (autologous to allogeneic), compared to $150,000-$400,000 in the USA — with equivalent outcomes at accredited centres.
Life Rx Healthcare partners with India's most trusted oncology centres — all JCI or NABH accredited, all with dedicated international patient infrastructure.
Apollo Hospital operates a network of cancer centres across India's major cities. Apollo Proton Cancer Centre in Chennai is South Asia's first and most advanced proton therapy facility, treating patients from over 120 countries with dedicated international oncology coordinators and structured pre-travel planning.
Best for: Proton therapy · Robotic oncology surgery · Haemato-oncology · Precision medicine
.webp)
One of India's highest-volume oncology centres, consistently ranked among Asia's top cancer hospitals. The multidisciplinary tumour board approach — where every complex case is reviewed by surgeons, oncologists, radiologists, and pathologists collectively — mirrors the protocol at leading Western cancer centres.
Best for: Bone marrow transplant · Complex oncological surgery · Haematology
Medanta's Cancer Institute integrates oncology, nuclear medicine, robotic surgery, and palliative care. Its radiosurgery programme uses TrueBeam and CyberKnife technology for high-precision, non-invasive radiation treatment.
Best for: Robotic surgery · Head & neck cancers · Lung cancer · Multidisciplinary tumour boards
BLK-Max holds a particular reputation for haemato-oncology and BMT — regularly ranked among India's top 3 blood cancer programmes. Max Saket covers all solid tumours with comprehensive robotic and minimally invasive oncology.
Best for: Blood cancers · BMT · Gynaecological oncology · Thoracic surgery
Manipal's cancer network across South India combines surgical, medical, and radiation oncology with molecular diagnostics and genomic testing. One of the early adopters of CAR-T cell therapy through NexCAR19 in southern India.
Best for: Colorectal cancer · Urology oncology · Breast cancer · CAR-T cell therapy
India's premier cancer institution — established 1941, managed under the Department of Atomic Energy. Handles one of the highest volumes of cancer cases in Asia. ACTREC in Kharghar is the original site of NexCAR19 CAR-T development and operates India's second proton therapy facility. The gold standard for blood cancers and complex surgical oncology.
Best for: All blood cancers · CAR-T therapy · Proton therapy · Head & neck surgery · Complex GI oncology
%20-%2021%20Centres%20Across%20India.webp)
HealthCare Global Enterprises operates the largest dedicated cancer hospital network in India, with centres in Mumbai, Bangalore, Ahmedabad, Visakhapatnam, and 17 other cities. HCG's cancer-only focus and broad geographic presence makes it particularly accessible for patients who want to avoid the largest metros.
Best for: Specialised cancer-only focus · Radiation oncology · Molecular profiling · Competitive pricing
These are all-inclusive estimated costs in USD covering surgery/treatment, hospital stay, investigations, anaesthesia, and immediate post-operative care. They do not include international flights or family accommodation.
| Cancer Type | Treatment | India Cost (USD) | USA Cost (USD) | Saving |
| Breast Cancer | Surgery + Chemotherapy + Radiation | $8,000 - $18,000 | $80,000 - $150,000 | ~85% |
| Lung Cancer | Surgery (VATS / Robotic) | $9,000 - $15,000 | $50,000 - $100,000 | ~83% |
| Prostate Cancer | Robotic Prostatectomy | $5,000 - $10,000 | $30,000 - $60,000 | ~83% |
| Colorectal Cancer | Laparoscopic / Robotic Surgery | $6,000 - $12,000 | $40,000 - $80,000 | ~83% |
| Blood Cancer (Lymphoma / Leukaemia) | Chemotherapy + Bone Marrow Transplant (BMT) | $25,000 - $55,000 | $200,000 - $400,000 | ~87% |
| Liver Cancer | Resection or Transplant | $20,000 - $45,000 | $80,000 - $300,000 | ~80% |
| Pancreatic Cancer | Whipple Surgery + Chemotherapy | $10,000 - $18,000 | $60,000 - $120,000 | ~83% |
| Ovarian Cancer | Debulking Surgery + Chemotherapy | $8,000 - $15,000 | $50,000 - $100,000 | ~83% |
| Cervical Cancer | Surgery + Radiation / Chemotherapy | $7,000 - $14,000 | $40,000 - $80,000 | ~82% |
| Brain Tumour | Surgery + Radiosurgery | $10,000 - $20,000 | $70,000 - $150,000 | ~86% |
India has emerged as a leading destination for cancer treatment, offering world-class oncology care, advanced technologies, and significant cost savings without compromising clinical outcomes. However, successful treatment abroad requires more than choosing the right hospital—it requires the right guidance.
With over 20 years of experience and more than 15,000 international patients served across 100+ countries, Life Rx Healthcare stands apart as a trusted oncology facilitation partner. Unlike conventional medical tourism agents, we provide personalized support, unbiased hospital selection, and access to the most suitable cancer specialists for each patient's unique condition. From treatment planning and travel coordination to post-treatment follow-up, we ensure a seamless, safe, and patient-focused experience—because in cancer care, every decision matters.
